Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Maria E. Farrugia"'
Autor:
Robert Muni-Lofra, Lindsay B. Murphy, Kate Adcock, Maria E. Farrugia, Joseph Irwin, James B. Lilleker, John McConville, Andria Merrison, Matt Parton, Liz Ryburn, Mariacristina Scoto, Chiara Marini-Bettolo, Anna Mayhew
Publikováno v:
Frontiers in Neurology, Vol 13 (2022)
Spinal Muscular Atrophy (SMA) is characterized by muscle atrophy and weakness and has an incidence of 1:11. 000 live births which projects an estimated population in the UK of 650–1,300 affected patients. Standards of Care (SoC) were updated in 201
Externí odkaz:
https://doaj.org/article/a9f7abf93e734fd8b66d6c2902924e3d
Autor:
John P Bourke, Robert McFarland, John O'Sullivan, Yi Shiau Ng, Doug M Turnbull, Albert Zishen Lim, Daniel M Jones, Matthew G D Bates, Andrew M Schaefer, Catherine Feeney, Maria E Farrugia, Gráinne S Gorman
Publikováno v:
Open Heart, Vol 8, Iss 1 (2021)
Objective Regular cardiac surveillance is advocated for patients with primary mitochondrial DNA disease. However, there is limited information to guide clinical practice in mitochondrial conditions caused by nuclear DNA defects. We sought to determin
Externí odkaz:
https://doaj.org/article/90054628b24a4e5babbabd4aa95f3898
Autor:
Mark J Hamilton, Yvonne Robb, Sarah Cumming, Helen Gregory, Alexis Duncan, Monika Rahman, Anne McKeown, Catherine McWilliam, John Dean, Alison Wilcox, Maria E Farrugia, Anneli Cooper, Josephine McGhie, Berit Adam, Richard Petty, Scottish Myotonic Dystrophy Consortium, Cheryl Longman, Iain Findlay, Alan Japp, Darren G Monckton, Martin A Denvir
Publikováno v:
PLoS ONE, Vol 12, Iss 3, p e0174166 (2017)
ObjectiveHigh sensitivity plasma cardiac troponin-I (cTnI) is emerging as a strong predictor of cardiac events in a variety of settings. We have explored its utility in patients with myotonic dystrophy type 1 (DM1).Methods117 patients with DM1 were r
Externí odkaz:
https://doaj.org/article/d5d3a07f0d044a9eaff8ffc4d1e835f1
Autor:
Srikanth Muppidi, Jeffrey T Guptill, Saiju Jacob, Yingkai Li, Maria E Farrugia, Amanda C Guidon, Jinny O Tavee, Henry Kaminski, James F Howard, Gary Cutter, Heinz Wiendl, Matthew B Maas, Isabel Illa, Renato Mantegazza, Hiroyuki Murai, Kimiaki Utsugisawa, Richard J Nowak, Alok Tyagi, Ana Paula Sousa, Anthony A Amato, Ashwin Pinto, Bhaskar Roy, Caroline Carmichael, Dubravka Dodig, Georgina Burke, Gary R Cutter, Henry J Kaminski, Ikjae Lee, Jeffrey Guptill, James F. Howard, James Caress, Jane Pritchard, John Vissing, Kamla Best, Mahtab Ramezani, Mathew Maas, Michael K Hehir, Michelle Kaku, Natalia Jiménez Esquivel, Paul Gallagher, Paul Maddison, Philip A Ambrose, Renato E Mantegazza, Rocio Vazquez Do Campo, Sami Saba, Shahriar Nafissi, Shannon Itoyama, Stuart Viegas Viegas, Victoria Marshall, Yingkai Li Li
Publikováno v:
LANCET NEUROLOGY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
The Lancet. Neurology
The Lancet Neurology
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
The Lancet. Neurology
The Lancet Neurology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5728d2028ac5938c7dda87e81a9e0bc
https://doi.org/10.1016/s1474-4422(20)30413-0
https://doi.org/10.1016/s1474-4422(20)30413-0
Publikováno v:
Seminars in Ophthalmology. 33:429-434
Introduction: Medical management can have limitations in improving ptosis in patients with myasthenia gravis (MG). We present our experience of ptosis surgery in MG. Materials and Methods: Clinical records of all patients with MG undergoing ptosis su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c51c594b8e46ec95fb639e2f29493d0a
https://doi.org/10.1080/08820538.2017.1284871
https://doi.org/10.1080/08820538.2017.1284871
Autor:
Jon, Sussman, Maria E, Farrugia, Paul, Maddison, Marguerite, Hill, M Isabel, Leite, David, Hilton-Jones
Publikováno v:
Annals of the New York Academy of Sciences. 1412(1)
Myasthenia gravis (MG) is an autoimmune disease of the neuromuscular junction for which many therapies were developed before the era of evidence-based medicine. Despite the basic principles of treatment being well known, patients continue to receive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f3089ffdb7a4a106c02f4da67afe9481
https://pubmed.ncbi.nlm.nih.gov/29121404
https://pubmed.ncbi.nlm.nih.gov/29121404
Autor:
Maria E, Farrugia, Caroline, Carmichael, Bryan J, Cupka, Judy, Warder, Kathryn M, Brennan, Ted M, Burns
Publikováno v:
Musclenerve. 50(4)
We explored the modified Rankin scale (mRS) as a tool to quantitate disability in myasthenia gravis (MG). Our aim was to correlate patients' perception of their disability with that of the care provider and determine its relationship with other MG-re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9cffaba1eab8882c1028b619f3e917a1
https://pubmed.ncbi.nlm.nih.gov/24639179
https://pubmed.ncbi.nlm.nih.gov/24639179
Publikováno v:
Musclenerve. 43(3)
The Oculobulbar Facial Respiratory (OBFR) score is a tool that objectively measures bulbar function in myasthenia gravis (MG). In this study, we analyzed the relation between the OBFR and the MG Activities of Daily Living (MG-ADL) score, and also wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d7d6037c47348348850ee057666ac987
https://pubmed.ncbi.nlm.nih.gov/21305562
https://pubmed.ncbi.nlm.nih.gov/21305562
Autor:
Mark J Hamilton, Yvonne Robb, Sarah Cumming, Helen Gregory, Alexis Duncan, Monika Rahman, Anne McKeown, Catherine McWilliam, John Dean, Alison Wilcox, Maria E Farrugia, Anneli Cooper, Josephine McGhie, Berit Adam, Richard Petty, Scottish Myotonic Dystrophy Consortium, Cheryl Longman, Iain Findlay, Alan Japp, Darren G Monckton, Martin A Denvir
Publikováno v:
PLoS ONE, Vol 12, Iss 4, p e0175615 (2017)
[This corrects the article DOI: 10.1371/journal.pone.0174166.].
Externí odkaz:
https://doaj.org/article/56a3cbe0541c4295bf62c35bfe38c55f